Pharmaceutical firms have devoted substantial lobbying efforts and dollars into fighting cannabis…
…this study’s finding that “cannabis entry decreases returns for both generic and brand drug makers is novel,” the California Polytechnic State University and University of New Mexico researchers said.
…study concludes, citing the fact that Pfizer spent billions to acquire a “biotech company that focuses on cannabinoid-type therapies.”
Original Article (Marijuana Moment):
Pharmaceutical industry suffers billions in losses after states legalize marijuana, new study finds
Artwork Fair Use: Jim.henderson